Abstract:Abstract Background: Hepatocellular carcinoma (HCC) is one of the leading causes of mortality worldwide. N6-methyladenosine (m6A) methyltransferase, has been proved to act as an oncogene in several human cancers. However, little is known about its relationship with the long non-coding RNAs (lncRNAs) that remains elusive in HCC.Methods: We comprehensively integrated gene expression data acquired from 371 HCC and 50 normal tissues in The Cancer Genome Atlas (TCGA) database. Differentially expressed protein-coding genes (DE-PCGs)/lncRNAs (DE-lncRs) analysis and univariate regression & Kaplan-Meier (K-M) analysis was performed to identify m6A methyltransferase‑related lncRNAs that were related to overall survival (OS). m6A methyltransferase‑related lncRNA signature was constructed using the Least absolute shrinkage and selection operator (LASSO) Cox regression analyses. Furthermore, Cox regression analysis was applied to identify independent prognostic factors in HCC. The signature was validated in an internal validation set. Finally, the correlation analysis between gene signature and immune cells infiltration was also investigated via single-sample Gene Set Enrichment Analysis (ssGSEA) and immunotherapy response was calculated through Tumor Immune Dysfunction and Exclusion (TIDE) algorithm.Results: A total of 21 m6A methyltransferase-related lncRNAs were screened out according to Spearman correlation analysis with the immune score (|R| > 0.3, P < 0.05). We selected 3 prognostic lncRNAs to construct m6A methyltransferase-related lncRNA signature through univariate and LASSO Cox regression analyses. The univariate and multivariate Cox regression analyses demonstrated that the lncRNAs signature was a robust independent prognostic factor in OS prediction with high accuracy. The GSEA also suggested that the m6A methyltransferase-related lncRNAs were involved in the immune-related biological processes and pathways which were very well-known in the context of HCC tumorigenesis. Besides, we found that the lncRNAs signature was strikingly correlated with the tumor microenvironment (TME) immune cells infiltration and expression of critical immune checkpoints. Finally, results from the TIDE analysis revealed that the m6A methyltransferase-related lncRNAs could efficiently predict the clinical response of immunotherapy in HCC.Conclusion: Together, our study screened potential prognostic m6A methyltransferase related lncRNAs and established a novel m6A methyltransferase-based prognostic model of HCC, which not only provides new potential prognostic biomarkers and therapeutic targets but also deepens our understanding of tumor immune microenvironment status and lays a theoretical foundation for immunotherapy.

Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription.

MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions

The role of long non-coding RNA MIAT in cancers

Transcriptome Sequencing of Hepatocellular Carcinoma Uncovers Multiple Types of Dysregulated Ncrnas

Investigation into the Role of Long-Non-Coding RNA MIAT in Leukemia

Transcriptome Profiling of Hepatocellular Carcinoma Uncovers Multi-Types of Dysregulated ncRNAs

lncRNA miat functions as a ceRNA to upregulate sirt1 by sponging miR-22-3p in HCC cellular senescence.

The LncRNA MIAT is identified as a regulator of stemness-associated transcript in glioma

Function and Clinical Potential of Micrornas in Hepatocellular Carcinoma

The Lncrna Myocardial Infarction Associated Transcript-Centric Competing Endogenous RNA Network in Non-Small-cell Lung Cancer.

The Paradoxical Functions of Long Noncoding RNAs in Hepatocellular Carcinoma: Implications in Therapeutic Opportunities and Precision Medicine

Significance of m 6A Methyltransferase‑Related lncRNAs in the Prognosis and Immunotherapy of Hepatocellular Carcinoma

Long Non-Coding RNA Myocardial Infarction Associated Transcript Promotes the Proliferation of Cholangiocarcinoma Cells by Targeting Mir-551B-3p/ccnd1 Axis

The Role and Clinical Implications of Micrornas in Hepatocellular Carcinoma

Role of LncRNA MIAT in Diabetic Complications

Progress and Prospects of Long Noncoding RNAs (lncrnas) in Hepatocellular Carcinoma.

Comprehensive Analysis Of Long Non-Coding Rna-Messenger Rna-Microrna Co-Expression Network Identifies Cell Cycle-Related Lncrna In Hepatocellular Carcinoma

Functional long non-coding RNAs in hepatocellular carcinoma

Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma